Philips Medical System is the diagnostics business of Royal Philips Electronics of the Netherlands, one of the world's biggest electronics companies and Europe's largest. Philips is quoted on the NYSE (symbol: PHG), London, Frankfurt, Amsterdam and other stock exchanges. On October 19, 2001, Philips Medical Systems completed a 3-year acquisition strategy through its purchase of Marconi Medical Systems. Marconi Medical Systems offered leading multislice CT, MRI, and Nuclear Gamma Camera systems to medical institutions around the world. As well as new 3.0T developments, Philips is also in collaboration with researchers at the University of Nottingham, with the intention of developing an ultrahigh field strength clinical 7.0T whole body MR system.

MRI Scanners:

0.23T to 1.0T:
1.5T:
3.0T to 7.0T:
Hybrid Scanners:

On October 19, 2001, Philips Medical Systems completed an acquisition strategy through its purchase of Marconi Medical Systems.

The History of Marconi Medical Systems
2001 Royal Philips Electronics and Marconi plc announced that Philips has agreed to acquire Marconi Medical Systems for $1.1 billion.
2000 Marconi introduces Infinite Detector Technology for Mx8000 multislice CT scanner, which acquires an unprecedented 16 simultaneous slices with sub-millimeter isotropic accuracy.
1999 At RSNA, Picker International unveils the new Marconi Medical Systems name and corporate vision.
1998 Picker International acquires the Computed Tomography Division of Elscint Ltd, immediately positioning Picker at the forefront of major global CT suppliers.
1986 Picker produces the industry's first 1.0T MR imager.
1981 Picker is sold to General Electric Co. Ltd. of England (GEC). Picker merged with Cambridge Instruments, GEC Medical, and American Optical to form Picker International.
1967 The name changed from Picker X-ray to Picker Corporation. Picker acquired Dunlee.
1946 The Dunlee Corporation started in Chicago by Dunmore Dunk and Zed. J. Atlee to meet demand for quality X-ray tubes and special purpose tubes.
1915 James Picker Company formed in New York City offering sales and service of X-ray equipment, film and accessories.

See also Philips Medical Systems and MRI History.

[This entry is marked for removal.]

(July 20, 2009 - EPIX Pharmaceuticals, Inc. announced today that, in light of the company's lack of capital and inability to obtain additional financing or consummate a strategic transaction, it has entered into an Assignment for the Benefit of Creditors, effective immediately, in accordance with Massachusetts law).
EPIX has been a specialty pharmaceutical firm developing targeted contrast agents to improve the capability of MRI as a diagnostic tool for a variety of diseases. Gadofosveset trisodium (formerly MS-325, Vasovist™, now ABLAVARt™), is an injectable intravascular contrast agents designed for multiple vascular imaging applications, including peripheral vascular disease and coronary artery disease. EPIX conducted a pivotal Phase III trial for the detection of peripheral vascular disease, as well as a Phase II feasibility trial for coronary artery disease diagnosis.
To ensure rapid development and adoption of gadofosveset trisodium into clinical practice upon regulatory approval, EPIX pursued an aggressive product development plan and commercialization strategy. The Company established an exclusive, worldwide sales and marketing agreement with Bayer Schering Pharma AG. EPIX also established corporate collaborations with GE Healthcare, Philips Medical Systems and Siemens Medical Systems, the three leading MRI manufacturers, which together account for approximately 80 percent of the MRI machines installed worldwide.
EPIX had other MRI contrast agents under development, most significantly a novel prototype blood clot agent (EP-2104R). Potential clinical applications for this type of agent include detection of deep venous thrombosis, pulmonary embolism and blood clots in the coronary and carotid arteries. Currently, there is no high resolution imaging technique to directly visualize blood clots in patients with suspected cardiovascular disease.

From Philips Medical Systems; Philips Infinion 1.5 T is designed to maximize the efficiency and quality of patient care. Developed with the patient in mind, the Infinion is the shortest and most open 1.5T scanner available. The unique 'ultra short' 1.4 m magnet assures patient comfort and acceptance without compromising image quality and clinical performance.

From Philips Medical Systems;
this low field MRI system of the Intera-family is onto diagnostic safety and flexibility aligned - cost effective and with high patient acceptance.